WALD trades 50.6% below Wall Street's consensus target of $2.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes WALD achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Waldencast plc (WALD) has a Wall Street consensus price target of $2.50, based on estimates from 4 covering analysts. With the stock currently trading at $1.66, this represents a potential upside of +50.6%. The company has a market capitalization of $196M.
Analyst price targets range from a low of $2.00 to a high of $3.00, representing a 40% spread in expectations. The median target of $2.50 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, WALD trades at a trailing P/E of -0.8x. Analysts expect EPS to grow +76.2% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ELFe.l.f. Beauty, Inc. | $3.8B | $64.20 | $74.78 | +16.5% | Buy | 19.5x | 27 |
COTYCoty Inc. | $1.7B | $1.95 | $3.94 | +102.1% | Hold | 8.8x | 33 |
IPARInter Parfums, Inc. | $3.2B | $99.09 | $112.00 | +13.0% | Buy | 20.3x | 19 |
SKINThe Beauty Health Company | $86M | $0.66 | $1.53 | +130.8% | Hold | — | 14 |
ELThe Estée Lauder Companies Inc. | $30.6B | $84.81 | $102.08 | +20.4% | Hold | 34.9x | 46 |
ULTAUlta Beauty, Inc. | $19.6B | $456.13 | $671.13 | +47.1% | Buy | 15.9x | 47 |
KVYOKlaviyo, Inc. | $4.0B | $13.25 | $31.41 | +137.1% | Buy | 15.6x | 22 |
CENTCentral Garden & Pet Company | $2.7B | $43.18 | $54.00 | +25.1% | Buy | 14.6x | 10 |
HIMSHims & Hers Health, Inc. | $7.8B | $35.47 | $28.08 | -20.8% | Hold | — | 20 |
PGThe Procter & Gamble Company | $351.4B | $150.38 | $159.00 | +5.7% | Buy | 21.8x | 52 |
Quick answers to the most common questions about buying WALD stock.
The consensus Wall Street price target for WALD is $2.5, representing 50.6% upside from the current price of $1.66. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
WALD has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $2.5 implies 50.6% upside from current levels.
WALD's current price is $1.66 with a consensus target of $2.5 (50.6% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $3 for WALD, while the most conservative target is $2. The consensus of $2.5 represents the median expectation. These targets typically reflect 12-month expectations.
WALD is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month WALD stock forecast based on 4 Wall Street analysts shows a consensus price target of $2.5, with estimates ranging from $2 (bear case) to $3 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on WALD, with a "Buy" consensus rating and $2.5 price target (50.6% upside). 2 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
WALD analyst price targets range from $2 to $3, a 40% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $2.5 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.